» Articles » PMID: 17620471

Hyperattenuating Renal Masses: Etiologies, Pathogenesis, and Imaging Evaluation

Overview
Journal Radiographics
Specialty Radiology
Date 2007 Jul 11
PMID 17620471
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Some renal masses have higher attenuation than the surrounding renal parenchyma at computed tomography (CT). Their hyperattenuation is usually the result of proteinaceous fluid or densely packed cells. Most hyperattenuating renal masses are benign hemorrhagic or proteinaceous cysts. However, solid enhancing hyperattenuating renal masses may have malignant as well as benign causes. Possible malignant causes include renal cell carcinoma and lymphoma; benign causes include angiomyolipoma with minimal fat. It is important to identify the cause of a hyperattenuating renal mass so as to avoid unnecessary surgical resection or ablation. CT may be useful for diagnosing benign hyperattenuating renal cysts, hematomas, and vascular anomalies that appear masslike. However, some solid, enhancing, hyperattenuating masses cannot be diagnosed confidently with CT alone: Small (< or = 3-cm-diameter), homogeneously enhancing, hyperattenuating renal masses depicted on CT images may be either benign angiomyolipomas with minimal fat or renal cell carcinomas. Magnetic resonance (MR) imaging may be helpful for differentiating between angiomyolipomas with minimal fat and clear cell renal cell carcinomas; however, differentiation between angiomyolipomas with minimal fat and papillary renal cell carcinomas often is not possible on the basis of MR imaging. In such cases, a percutaneous biopsy may be useful for diagnosis. If the results of MR imaging and percutaneous biopsy are not definitive, surgery is warranted.

Citing Articles

Renal angiomyolipomas: Typical and atypical features on computed tomography and magnetic resonance imaging.

Labra A, Schiappacasse G, Constenla D, Cristi J World J Radiol. 2025; 17(2):104282.

PMID: 40060953 PMC: 11885927. DOI: 10.4329/wjr.v17.i2.104282.


CEUS Bosniak Classification-Time for Differentiation and Change in Renal Cyst Surveillance.

Moller K, Jenssen C, Correas J, Safai Zadeh E, Bertolotto M, Ignee A Cancers (Basel). 2023; 15(19).

PMID: 37835403 PMC: 10571952. DOI: 10.3390/cancers15194709.


Multimodality imaging of Xp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma: a case report.

Huang W, Peng Y, Zhang Y, Qiu Y, Liu Y, Wang A Front Med (Lausanne). 2023; 10:1266630.

PMID: 37795411 PMC: 10546202. DOI: 10.3389/fmed.2023.1266630.


Renal epithelioid angiomyolipoma: A case report.

Li H, Zhang X, Zhao Q, Wang J, Yang X, Huang S Oncol Lett. 2023; 26(3):409.

PMID: 37600337 PMC: 10436154. DOI: 10.3892/ol.2023.13995.


Peripheral nodular enhancement in adrenal and renal hematomas: A report of 3 cases.

Russell G, Navale P, Ludwig D, Strnad B, Itani M Radiol Case Rep. 2023; 18(10):3371-3375.

PMID: 37502475 PMC: 10369399. DOI: 10.1016/j.radcr.2023.07.020.